InterScience Aims to Ensure Accurate Medical Information Reaches Everyone #Japan #Tokyo #Rare_Diseases #Interscience #Medicil
Sobi Unveils Its Comprehensive Annual and Sustainability Report for 2025 #Sustainability #Sweden #Stockholm #Sobi #Rare_Diseases
Sobi's Comprehensive Annual and Sustainability Report for 2025 Highlights Growth and Commitment to Rare Diseases #Sweden #Stockholm #Annual_Report #Sobi #Rare_Diseases
NORD Strengthens Rare Disease Advocacy with New Leadership Appointments #USA #Washington #Rare_Diseases #NORD #policy_leadership
Mediaplanet Launches Nationwide Rare Disease Awareness Campaign #Rare_Diseases #Awareness_Campaign #Mediaplanet
AOP Health Standardizes Veeva Industry Cloud Across All Business Areas for Enhanced Integration #USA #Veeva_Systems #Pleasanton #Rare_Diseases #AOP_Health
AOP Health Streamlines Operations Using Veeva Industry Cloud for Life Sciences #USA #Veeva_Systems #Pleasanton #Rare_Diseases #AOP_Health
Andelyn Biosciences Launches Foundation to Assist Families Facing Rare Diseases #United_States #Columbus #Rare_Diseases #Andelyn_Biosciences #Andelyn_Foundation
The Surge to Save Newborns Coalition: Aiming to Standardize Newborn Screening Across States #United_States #Washington #Rare_Diseases #newborn_screening #Surge_to_Save
Over 30 Million Americans Affected by Rare Diseases: A Call for Action #United_States #Washington,_D.C. #Rare_Diseases #NORD #Health_Advocacy
National Report Highlights Variability in Rare Disease Access Across States #Healthcare_Access #Rare_Diseases #NORD
NIH Director Dr. Jay Bhattacharya to Lead NORD Rare Disease Symposium for Innovative Solutions #United_States #Arlington #Rare_Diseases #NIH #NORD
Health Union Launches New Digital Communities for Oncology and Rare Diseases to Enhance Patient Engagement #USA #Philadelphia #oncology #Rare_Diseases #Health_Union
n-Lorem and EspeRare Unite to Enhance Access to Rare Disease Therapies in Europe #Switzerland #Rare_Diseases #Geneva #EspeRare #n-Lorem
Veeva Systems and BioMarin Pharmaceutical Forge Strategic Partnership to Accelerate Therapeutics Development #United_States #Veeva_Systems #Rare_Diseases #BioMarin_Pharmaceutical #Pleasanton,_San_Rafael
Orphalan's Acquisition of Orphelia Pharma: A Leap Forward in Rare Disease Treatment #Paris #France #Rare_Diseases #Orphalan #Orphelia
Kim Isenberg Joins NORD Board to Strengthen Advocacy for Rare Diseases #United_States #Rare_Diseases #NORD #Norwell #Kim_Isenberg
NORD Expands Its Network with Seven New Centers for Rare Diseases Across the U.S. #United_States #Rare_Diseases #NORD #Centers_of_Excellence #Norwell
Orphan Drugs Market Set to Reach $486.51 Billion by 2032 Amidst Rare Disease Innovations #Rare_Diseases #gene_therapies #Orphan_Drugs #United_States_and_Japan #Austin,_Texas_and_Tokyo
NORD Issues Request for Proposals to Establish New Patient Registries #USA #Rare_Diseases #Danbury #NORD #IAMRARE
NORD Launches an Innovative Mobile App for Rare Disease Advocacy and Research #United_States #Rare_Diseases #Danbury #NORD #IAMRARE
Orsini Unveils Comprehensive Pharmacy and Logistics Solution in Columbus, Ohio #United_States #Columbus #Rare_Diseases #Specialty_Pharmacy #Orsini
Pacific Northwest Research Institute Makes Progress in Rare Disease Research Amid Funding Challenges #United_States #Seattle #Rare_Diseases #Pacific_Northwest #genetic_research
Inpharmus Expands Global Presence in Rare Diseases and Oncology to Become a Market Leader #Istanbul #oncology #Turkey #Rare_Diseases #Inpharmus
Orsini and Paynela Join Forces to Enhance Access to Care for Rare Disease Patients #United_States #Elk_Grove_Village #Rare_Diseases #Orsini #Paynela
EQT Foundation Launches Grant Program for Rare Disease Research Innovations #Sweden #Stockholm #Rare_Diseases #EQT_Foundation #Breakthrough_Science
NORD Launches Free Data Literacy Course for Rare Diseases Community Empowering Patients and Caregivers #USA #Rare_Diseases #Danbury #NORD #Data_Literacy
Join the Movement: NORD's 2025 Summit Aims to Propel Rare Disease Innovation to New Heights #Rare_Diseases #NORD #Breakthrough_Summit
Citizen Health Secures $30 Million to Innovate Patient Advocacy with AI Technology #United_States #San_Francisco #Rare_Diseases #Citizen_Health #AI_Advocate
Happy to share data from the #JadavjiLab. A nice collaboration between us, Mitra Esfandiarei, Theresa Currier Thomas, and Tala Curry-Koski. We have expanded our research into #Rare_Diseases (MarfanSyndrome) to investigate the impact of vascular disease on neurodegeneration in the brain!